Výsledky hledání pro autora

1

Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor. Autor Vlassara, H, Moldawer, L, Chan, B

Vydáno 1989

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
2

Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Autor Vlassara, H, Brownlee, M, Cerami, A

Vydáno 1981

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
3

High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Autor Vlassara, H, Brownlee, M, Cerami, A

Vydáno 1985

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
4

Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for... Autor Zheng, F., Cai, W., Mitsuhashi, T., Vlassara, H.

Vydáno 2001

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
5

Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Autor Vlassara, H., Fuh, H., Donnelly, T., Cybulsky, M.

Vydáno 1995

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
6

Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix. Autor Mitsuhashi, T, Li, Y M, Fishbane, S, Vlassara, H

Vydáno 1997

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
7

Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE. Autor He, C. J., Koschinsky, T., Buenting, C., Vlassara, H.

Vydáno 2001

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
8

Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. Autor Kirstein, M, Aston, C, Hintz, R, Vlassara, H

Vydáno 1992

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
9

Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Autor Bucala, R, Makita, Z, Koschinsky, T, Cerami, A, Vlassara, H

Vydáno 1993

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
10

Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis. Autor Li, J. J., Dickson, D., Hof, P. R., Vlassara, H.

Vydáno 1998

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
11

Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Autor Kirstein, M, Brett, J, Radoff, S, Ogawa, S, Stern, D, Vlassara, H

Vydáno 1990

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
12

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Autor Vlassara, H, Fuh, H, Makita, Z, Krungkrai, S, Cerami, A, Bucala, R

Vydáno 1992

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
13

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Autor Bucala, R, Makita, Z, Vega, G, Grundy, S, Koschinsky, T, Cerami, A, Vlassara, H

Vydáno 1994

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
14

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Autor Vlassara, H, Striker, L J, Teichberg, S, Fuh, H, Li, Y M, Steffes, M

Vydáno 1994

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
15

Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Autor Doi, T, Vlassara, H, Kirstein, M, Yamada, Y, Striker, G E, Striker, L J

Vydáno 1992

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
16

Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Autor Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., Archer, D. B., Vlassara, H.

Vydáno 1997

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
17

Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Autor Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F. T., Cerami, A.

Vydáno 1995

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
18

Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Autor Li, Y M, Steffes, M, Donnelly, T, Liu, C, Fuh, H, Basgen, J, Bucala, R, Vlassara, H

Vydáno 1996

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
19

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Autor Yang, C W, Vlassara, H, Peten, E P, He, C J, Striker, G E, Striker, L J

Vydáno 1994

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:
20

Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Autor Nakamura, Y., Horii, Y., Nishino, T., Shiiki, H., Sakaguchi, Y., Kagoshima, T., Dohi, K., Makita, Z., Vlassara, H., Bucala, R.

Vydáno 1993

Získat plný text Získat plný text
Text

Přidat do oblíbených

Uloženo v:

Výsledky vyhledávání - Vlassara, H

Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor. Autor Vlassara, H, Moldawer, L, Chan, B

Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Autor Vlassara, H, Brownlee, M, Cerami, A

High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Autor Vlassara, H, Brownlee, M, Cerami, A

Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for... Autor Zheng, F., Cai, W., Mitsuhashi, T., Vlassara, H.

Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Autor Vlassara, H., Fuh, H., Donnelly, T., Cybulsky, M.

Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix. Autor Mitsuhashi, T, Li, Y M, Fishbane, S, Vlassara, H

Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE. Autor He, C. J., Koschinsky, T., Buenting, C., Vlassara, H.

Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. Autor Kirstein, M, Aston, C, Hintz, R, Vlassara, H

Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Autor Bucala, R, Makita, Z, Koschinsky, T, Cerami, A, Vlassara, H

Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis. Autor Li, J. J., Dickson, D., Hof, P. R., Vlassara, H.

Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Autor Kirstein, M, Brett, J, Radoff, S, Ogawa, S, Stern, D, Vlassara, H

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Autor Vlassara, H, Fuh, H, Makita, Z, Krungkrai, S, Cerami, A, Bucala, R

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Autor Bucala, R, Makita, Z, Vega, G, Grundy, S, Koschinsky, T, Cerami, A, Vlassara, H

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Autor Vlassara, H, Striker, L J, Teichberg, S, Fuh, H, Li, Y M, Steffes, M

Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Autor Doi, T, Vlassara, H, Kirstein, M, Yamada, Y, Striker, G E, Striker, L J

Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Autor Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., Archer, D. B., Vlassara, H.

Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Autor Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F. T., Cerami, A.

Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Autor Li, Y M, Steffes, M, Donnelly, T, Liu, C, Fuh, H, Basgen, J, Bucala, R, Vlassara, H

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Autor Yang, C W, Vlassara, H, Peten, E P, He, C J, Striker, G E, Striker, L J

Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Autor Nakamura, Y., Horii, Y., Nishino, T., Shiiki, H., Sakaguchi, Y., Kagoshima, T., Dohi, K., Makita, Z., Vlassara, H., Bucala, R.

Vyhledávací nástroje: